FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Fresenius Home Hemodialysis Guide Cleared

FDA clears a Fresenius Medical Care 510(k) for VersiHD with GuideMe Software, a self-guided interface for the companys VersiHD chronic home hemodialys...

latest-news-card-1
Human Drugs

Redx Orphan Status for Pulmonary Fibrosis

FDA grants Redx an orphan drug designation for zelasudil (RXC007) for treating idiopathic pulmonary fibrosis.

latest-news-card-1
Medical Devices

FDA Updates HeartWare Device Alert

Medtronic issues an Urgent Medical Device Communication about its HeartWare Ventricular Assist Device (HVAD) systems and a newly identified subgroup o...

latest-news-card-1
Human Drugs

Merck, Eisai Stop LEAP-010 Trial

Merck and Eisai terminate the Phase 3 LEAP-010 trial evaluating Mercks Keytruda (pembrolizumab) plus Eisais Lenvima (lenvatinib) in the first-line tre...

latest-news-card-1
Human Drugs

Finalized Informed Consent Guidance Analyzed

Ropes & Gray attorneys break down a new FDA final guidance on informed consent, highlighting changes from a previous draft.

latest-news-card-1
Human Drugs

FDA OKs New Veklury Covid Indication

FDA approves a Gilead Veklury sNDA eliminating the need for dose adjustments when treating Covid-19 in patients with mild, moderate, or severe hepatic...

latest-news-card-1
Human Drugs

Akebia Plans 3rd Quarter Vadadustat NDA Resubmission

Akebia Therapeutics says it plans to resubmit an NDA to FDA for vadadustat to treat anemia due to chronic kidney disease.

latest-news-card-1
Human Drugs

Fast Track for Abdominal Aneurysm Product

FDA grants Nectero Medical a fast track designation for its Endovascular Aneurysm Stabilization Treatment combination product for treating infrarenal ...

latest-news-card-1
Medical Devices

Paragonix Donor Lung Preservation Device Cleared

FDA clears a Paragonix Technologies 510(k) for its next-generation donor lung preservation system, BAROguard.

latest-news-card-1
Human Drugs

More Drug Approval Transparency Needed: Studies

Oregon State University says two research studies show that more drug approval transparency is needed.